Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory ...
The Trump administration has appointed Matthew Memoli, a veteran researcher who was critical of the U.S. response to the ...
A Trump administration order to freeze communication at the National Institutes of Health has disrupted scientific research ...
A memo from the NIH's acting director indicated research and clinical studies that began prior to Trump's inauguration can ...
A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to clinical trials, purchasing, research and the like.
Princeton received fewer awards in the past two fiscal years of 2023 and 2024 than in every year since 2011 and less funding ...
Despite concerns about the future of research at the National Institutes of Health, current clinical trials can continue as ...
Just days after President Trump imposed broad restrictions on communications, meetings, travel and public appearances at the ...
Acting NIH director Memoli clarifies communication restrictions as White House moves to freeze US government grants ...
Matthew Memoli, a National Institute of Allergy and ... hasn’t been scheduled yet. Though Memoli is an NIH insider, one source familiar with him noted his perspectives —particularly his ...
National Institutes of Health (NIH) Acting Director Matthew Memoli sought to clarify the extent of the Trump administration's freeze on communications and other functions within the Health and ...